Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: October 7, 2004
Last updated: May 22, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)